David H. Vesole, MD, PhD, discusses the importance of developing off-the-shelf CAR T-cell therapy products in multiple myeloma.
David Vesole, MD, PhD
Advertisement
Articles by David Vesole, MD, PhD
David H. Vesole, MD, PhD, discusses the advantages of CAR T-cell therapy in multiple myeloma.
Advertisement
Latest Updated Articles
Dr. Vesole on the Advantages of CAR T-Cell Therapy in Multiple MyelomaPublished: October 5th 2020 | Updated:
Dr. Vesole on Developing Off-the-Shelf CAR T-Cell Therapy in Multiple MyelomaPublished: October 9th 2020 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
MDA 2026 to Bring Keynote Insights and Evolving Neuromuscular Care
2
FDA Approves Waskyra as First Gene Therapy for Wiskott-Aldrich Syndrome
3
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial
4
CGTLive®’s Weekly Rewind – December 12, 2025
5
